Gynecologic Cancer
Guidelines
First-ever gestational trophoblastic neoplasia guidelines published
These rare tumors of pregnancy are generally curable with the appropriate risk-based therapies, experts say.
From the Journals
VEGF inhibitor shows promise in platinum resistant/refractory ovarian cancer
Combining the vascular endothelial growth factor (VEGF) receptor–targeting tyrosine kinase inhibitor apatinib with oral etoposide in people with...
Conference Coverage
Phase 2 trial: Dendritic cell vaccine maintenance prolongs PFS in EOC
DCVAC maintenance after chemotherapy prolonged progression-free survival by almost 6 months in EOC patients who have undergone primary debulking...
Gynecologic Oncology Consult
When is hysterectomy appropriate for cervical dysplasia?
In this month's Gynecologic Oncology Consult, Dr. Emma C. Rossi discusses critical counseling for cervical dysplasia patients offered hysterectomy...
Latest News
PARP inhibitors didn’t impair QOL as ovarian cancer maintenance therapy
Despite significant hematologic toxicities, PARP inhibitors did not adversely affect health-related quality of life for ovarian cancer patients....
From the Journals
ACA coverage mandate leads to more insurance for young women, early gynecologic cancer diagnoses
“These insurance gains have huge impacts on people’s lives,” Dr. Smith stated.
Conference Coverage
Immunogenicity of two-dose Gardasil 9 persists at 36 months
MALMO, SWEDEN – HPV type-specific antibody responses are as good or better than in 16- to 26-year-olds who got three...
From the Journals
IVF linked to slight increase in risk of some cancers
A large observational study found no increase in risk for uterine cancer, but small increases in risk of some breast and ovarian cancers in women...
From the Journals
Intensive nonaspirin NSAID use linked to reduced ovarian cancer mortality
Intensive use of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with improved survival of patients with serous ovarian...
From the Journals
HPV testing detects cervical precancers earlier than cytology
The HPV FOCAL study compared Pap liquid-based cytology with primary HPV testing.
From the Editor
Are we ready for primary HPV testing for the prevention of cervical cancer?
We may be at a tipping point where the iconic Pap smear is largely replaced by HPV testing for cervical cancer screening